Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,510 | 30,966 | 41,513 | 9,331 | 155 |
| Receivables | 3,984 | 3,614 | 357 | N/A | 35 |
| Other current assets | 0 | 0 | 0 | 1,080 | 0 |
| TOTAL | $68,228 | $36,411 | $43,416 | $11,595 | $689 |
| Non-Current Assets | |||||
| PPE Net | 165 | 143 | 228 | 20 | 48 |
| Other Non-Current Assets | 662 | 0 | 0 | 2 | 1,124 |
| TOTAL | $827 | $144 | $228 | $22 | $1,172 |
| Total Assets | $69,054 | $36,554 | $43,644 | $11,617 | $1,861 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,355 | 1,848 | 823 | 314 | 308 |
| Accrued Expenses | 3,916 | 4,285 | 2,273 | 1,712 | 50 |
| Other current liabilities | N/A | N/A | N/A | N/A | 38 |
| TOTAL | $7,443 | $6,967 | $3,938 | $3,146 | $1,562 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 375 |
| Deferred Revenues | 172 | 834 | 841 | 1,120 | 1,041 |
| TOTAL | $662 | $N/A | $N/A | $N/A | $1,495 |
| Total Liabilities | $8,105 | $6,967 | $3,938 | $3,146 | $3,058 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,561 | 13,215 | 9,200 | N/A | N/A |
| Common Shares | 14 | 10 | 9 | 2 | 0 |
| Retained earnings | -77,981 | -45,969 | -22,580 | -10,029 | -4,359 |
| Other shareholders' equity | 0 | 0 | 0 | 16,523 | 3,162 |
| TOTAL | $60,950 | $29,587 | $39,706 | $8,471 | $-1,197 |
| Total Liabilities And Equity | $69,054 | $36,554 | $43,644 | $11,617 | $1,861 |